# Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at Risk

> **NCT05787522** · — · COMPLETED · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 500 (actual)

## Conditions studied

- Lung Cancer
- Breast Cancer
- Esophageal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05787522
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-30
- **Primary completion:** 2023-07-27
- **Final completion:** 2024-03-06
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05787522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05787522, "Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at Risk". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05787522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*